Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Aust N Z J Psychiatry. 1999 Feb;33(1):84-8.

Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial.

Author information

  • 1Palmerston Centre, Hornsby Hospital, New South Wales, Australia.

Abstract

OBJECTIVE:

The aim of this study was to assess the efficacy of adjunctive megavitamin and dietary treatment in schizophrenia.

METHOD:

A random allocation double-blind, controlled comparison of dietary supplement and megavitamin treatment, and an alternative procedure was given for 5 months to 19 outpatients with a diagnosis of schizophrenia. In addition to usual follow-up, the experimental group received amounts of megavitamins based on their individual serum vitamin levels plus dietary restriction based on Radioallergosorbent (RAST) tests. The control group received 25 mg vitamin C and were prescribed substances considered allergenic from the RAST test.

RESULTS:

Five months of treatment showed marked differences in serum levels of vitamins but no consistent self-reported symptomatic or behavioural differences between groups.

CONCLUSIONS:

This study does not provide evidence supporting a positive relationship between regulation of levels of serum vitamins and clinical outcome in schizophrenia over 5 months.

PMID:
10197889
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk